Trigg Leslie's Form 4 filing
Outset Medical, Inc. (OM) · filed Jan 22, 2025
- Accession no.
- 0001484612-25-000025
- Filed
- Jan 22, 2025
- Trade date
- Jan 17-21, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $52.2K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Trigg LeslieCIK 0001304125 | Director, Officer (Chair and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | Common Stock | AGrant or awardAcquired | +99,419 | $0.00 | $0 | 960,816 | Direct | |
| Jan 21, 2025 | Common Stock | SSaleDisposed | −4,403 | $0.80 | −$3,522.4 | 956,413 | Direct | |
| Jan 21, 2025 | Common Stock | SSaleDisposed | −42,384 | $0.80 | −$33,907.2 | 914,029 | Direct | |
| Jan 21, 2025 | Common Stock | SSaleDisposed | −18,449 | $0.80 | −$14,759.2 | 895,580 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.